{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T17:37:44Z","timestamp":1762018664505,"version":"build-2065373602"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,4]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>ICU admissions due to complications of advanced liver disease continue to rise. Among indications for admission to the ICU in patients with cirrhosis, gastrointestinal issues such as bleeding are common. In patients in whom gastrointestinal issues are not the principal indication for ICU, gastrointestinal issues such as nutrition and ileus remain important concerns for generalized intensive care support. This review highlights current trends in management of gastrointestinal issues in patients with cirrhosis admitted to the ICU.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>General management of upper gastrointestinal bleeding remains largely unchanged. Improvements in interventional techniques have increased the options for difficult to control bleeding, these include the development of expandable esophageal stents and expanded experience with advanced interventional radiology techniques for the management of bleeding gastric varices. Frailty as an important prognostic marker in advanced liver disease and liver transplantation is the subject of several new studies and serves to highlight the importance of nutrition in the management of the critically ill cirrhotic patient.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Gastrointestinal complications are frequent in the critically ill cirrhotic patient. Recognition and intervention in a timely manner may minimize morbidity and mortality and result in improved outcomes for this vulnerable population.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mcc.0000000000000700","type":"journal-article","created":{"date-parts":[[2020,1,24]],"date-time":"2020-01-24T18:47:39Z","timestamp":1579891659000},"page":"186-191","source":"Crossref","is-referenced-by-count":4,"title":["The gastrointestinal system in the critically ill cirrhotic patient"],"prefix":"10.1097","volume":"26","author":[{"given":"Jody C.","family":"Olson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230913","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1097\/CCM.0000000000002961","article-title":"Incidence and outcomes for patients with cirrhosis admitted to the United Kingdom critical care units","volume":"46","author":"McPhail","year":"2018","journal-title":"Crit Care Med"},{"key":"R2-20230913","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1002\/hep.28812","article-title":"Time trends in the healthcare burden and mortality of acute on chronic liver failure in the United States","volume":"64","author":"Allen","year":"2016","journal-title":"Hepatology"},{"key":"R3-20230913","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1053\/j.gastro.2007.05.024","article-title":"Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis","volume":"133","author":"Ripoll","year":"2007","journal-title":"Gastroenterology"},{"key":"R4-20230913","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.gie.2006.08.023","article-title":"Endoscopic screening for varices in cirrhotic patients: data from a national endoscopic database","volume":"65","author":"Kovalak","year":"2007","journal-title":"Gastrointest Endosc"},{"key":"R5-20230913","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S0168-8278(02)00420-8","article-title":"Incidence and natural history of small esophageal varices in cirrhotic patients","volume":"38","author":"Merli","year":"2003","journal-title":"J Hepatol"},{"key":"R6-20230913","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1056\/NEJMoa044456","article-title":"Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis","volume":"353","author":"Groszmann","year":"2005","journal-title":"N Engl J Med"},{"key":"R7-20230913","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1053\/gast.1996.v111.pm8780575","article-title":"Prognostic value of hepatic venous pressure gradient measurements in alcoholic cirrhosis: a 10-year prospective study","volume":"111","author":"Vorobioff","year":"1996","journal-title":"Gastroenterology"},{"key":"R8-20230913","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/hep.1840050313","article-title":"Portal pressure, presence of gastroesophageal varices and variceal bleeding","volume":"5","author":"Garcia-Tsao","year":"1985","journal-title":"Hepatology"},{"key":"R9-20230913","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1056\/NEJM198810133191505","article-title":"Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study","volume":"319","year":"1988","journal-title":"N Engl J Med"},{"key":"R10-20230913","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.jhep.2015.10.019","article-title":"Management of the critically ill patient with cirrhosis: a multidisciplinary perspective","volume":"64","author":"Nadim","year":"2016","journal-title":"J Hepatol"},{"key":"R11-20230913","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1211801","article-title":"Transfusion strategies for acute upper gastrointestinal bleeding","volume":"368","author":"Villanueva","year":"2013","journal-title":"N Engl J Med"},{"key":"R12-20230913","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1365-2036.2011.04746.x","article-title":"Meta-analysis: antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding \u2013 an updated Cochrane review","volume":"34","author":"Chavez-Tapia","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"R13-20230913","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/hep.20126","article-title":"Antibiotic prophylaxis after endoscopic therapy prevents rebleeding in acute variceal hemorrhage: a randomized trial","volume":"39","author":"Hou","year":"2004","journal-title":"Hepatology"},{"key":"R14-20230913","doi-asserted-by":"crossref","first-page":"883","DOI":"10.3346\/jkms.2006.21.5.883","article-title":"Antibiotic prophylaxis using third generation cephalosporins can reduce the risk of early rebleeding in the first acute gastroesophageal variceal hemorrhage: a prospective randomized study","volume":"21","author":"Jun","year":"2006","journal-title":"J Korean Med Sci"},{"key":"R15-20230913","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.cgh.2014.11.019","article-title":"Risk of bacterial infection in patients with cirrhosis and acute variceal hemorrhage, based on child-pugh class, and effects of antibiotics","volume":"13","author":"Tandon","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R16-20230913","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/hep.28906","article-title":"Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases","volume":"65","author":"Garcia-Tsao","year":"2017","journal-title":"Hepatology"},{"key":"R17-20230913","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0140-6736(95)92708-5","article-title":"Early administration of terlipressin plus glyceryl trinitrate to control active upper gastrointestinal bleeding in cirrhotic patients","volume":"346","author":"Levacher","year":"1995","journal-title":"Lancet"},{"issue":"(Suppl 2)","key":"R18-20230913","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000051417","article-title":"Pharmacological treatment of acute variceal bleeding","volume":"59","author":"Burroughs","year":"1998","journal-title":"Digestion"},{"key":"R19-20230913","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1111\/j.1365-2036.2012.05088.x","article-title":"Meta-analysis: vasoactive medications for the management of acute variceal bleeds","volume":"35","author":"Wells","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"R20-20230913","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1177\/1060028014559244","article-title":"Use of proton pump inhibitors in the management of gastroesophageal varices: a systematic review","volume":"49","author":"Lo","year":"2015","journal-title":"Ann Pharmacother"},{"key":"R21-20230913","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1038\/s41395-018-0085-9","article-title":"Proton pump inhibitor initiation and withdrawal affects gut microbiota and readmission risk in cirrhosis","volume":"113","author":"Bajaj","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"R22-20230913","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1002\/hep.28737","article-title":"Proton pump inhibitors as a risk factor for hepatic encephalopathy and spontaneous bacterial peritonitis in patients with cirrhosis with ascites","volume":"64","author":"Dam","year":"2016","journal-title":"Hepatology"},{"key":"R23-20230913","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/liv.14012","article-title":"Effect of proton pump inhibitors on the risk and prognosis of infections in patients with cirrhosis and ascites","volume":"39","author":"Dam","year":"2019","journal-title":"Liver Int"},{"key":"R24-20230913","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jhep.2015.05.022","article-title":"Expanding consensus in portal hypertension: report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension","volume":"63","author":"de Franchis","year":"2015","journal-title":"J Hepatol"},{"key":"R25-20230913","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1002\/hep.28360","article-title":"Esophageal balloon tamponade versus esophageal stent in controlling acute refractory variceal bleeding: a multicenter randomized, controlled trial","volume":"63","author":"Escorsell","year":"2016","journal-title":"Hepatology"},{"key":"R26-20230913","doi-asserted-by":"crossref","first-page":"4054513","DOI":"10.1155\/2016\/4054513","article-title":"Esophageal stent for refractory variceal bleeding: a systemic review and meta-analysis","volume":"2016","author":"Shao","year":"2016","journal-title":"BioMed Res Int"},{"key":"R27-20230913","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1053\/he.2000.5852","article-title":"A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts","volume":"31","author":"Malinchoc","year":"2000","journal-title":"Hepatology"},{"key":"R28-20230913","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1007\/s10620-018-5412-x","article-title":"Predictors of re-bleeding and mortality among patients with refractory variceal bleeding undergoing salvage transjugular intrahepatic portosystemic shunt (TIPS)","volume":"64","author":"Maimone","year":"2019","journal-title":"Dig Dis Sci"},{"key":"R29-20230913","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1002\/hep.1840160607","article-title":"Prevalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients","volume":"16","author":"Sarin","year":"1992","journal-title":"Hepatology"},{"key":"R30-20230913","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1053\/jhep.2001.24116","article-title":"A prospective, randomized trial of butyl cyanoacrylate injection versus band ligation in the management of bleeding gastric varices","volume":"33","author":"Lo","year":"2001","journal-title":"Hepatology"},{"key":"R31-20230913","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1055\/s-2007-1005712","article-title":"Ethanolamine oleate versus butyl cyanoacrylate for bleeding gastric varices: a nonrandomized study","volume":"27","author":"Oho","year":"1995","journal-title":"Endoscopy"},{"key":"R32-20230913","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1111\/j.1572-0241.2002.05622.x","article-title":"A randomized controlled trial of cyanoacrylate versus alcohol injection in patients with isolated fundic varices","volume":"97","author":"Sarin","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"R33-20230913","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1007\/s10620-014-3485-8","article-title":"Balloon-occluded retrograde transvenous obliteration (BRTO) for treatment of gastric varices: review and meta-analysis","volume":"60","author":"Park","year":"2015","journal-title":"Dig Dis Sci"},{"key":"R34-20230913","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1046\/j.1440-1746.2003.03087.x","article-title":"Balloon-occluded retrograde transvenous obliteration improves liver function in patients with cirrhosis and portal hypertension","volume":"18","author":"Miyamoto","year":"2003","journal-title":"J Gastroenterol Hepatol"},{"key":"R35-20230913","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1051-0443(07)61912-5","article-title":"Long-term results of balloon-occluded retrograde transvenous obliteration for the treatment of gastric varices and hepatic encephalopathy","volume":"12","author":"Fukuda","year":"2001","journal-title":"J Vasc Interv Radiol"},{"key":"R36-20230913","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1053\/gast.2000.8555","article-title":"Natural history of portal hypertensive gastropathy in patients with liver cirrhosis. The New Italian Endoscopic Club for the study and treatment of esophageal varices (NIEC)","volume":"119","author":"Primignani","year":"2000","journal-title":"Gastroenterology"},{"key":"R37-20230913","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.dld.2010.10.006","article-title":"The management of portal hypertensive gastropathy and gastric antral vascular ectasia","volume":"43","author":"Ripoll","year":"2011","journal-title":"Dig Liver Dis"},{"key":"R38-20230913","first-page":"2030","article-title":"Acute gastrointestinal bleeding from portal hypertensive gastropathy: prevalence and clinical features","volume":"88","author":"Gostout","year":"1993","journal-title":"Am J Gastroenterol"},{"key":"R39-20230913","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1097\/00004836-200411000-00013","article-title":"Prevalence and natural history of gastric antral vascular ectasia in patients undergoing orthotopic liver transplantation","volume":"38","author":"Ward","year":"2004","journal-title":"J Clin Gastroenterol"},{"key":"R40-20230913","doi-asserted-by":"crossref","first-page":"263","DOI":"10.4253\/wjge.v9.i6.263","article-title":"Endoscopic resolution and recurrence of gastric antral vascular ectasia after serial treatment with argon plasma coagulation","volume":"9","author":"Garg","year":"2017","journal-title":"World J Gastrointest Endosc"},{"key":"R41-20230913","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1590\/S0004-28032006000400005","article-title":"Evaluation of nutritional status of nonhospitalized patients with liver cirrhosis","volume":"43","author":"Carvalho","year":"2006","journal-title":"Arq Gastroenterol"},{"key":"R42-20230913","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1111\/j.1478-3231.2009.02077.x","article-title":"Protein\u2013calorie malnutrition as a prognostic indicator of mortality among patients hospitalized with cirrhosis and portal hypertension","volume":"29","author":"Sam","year":"2009","journal-title":"Liver Int"},{"key":"R43-20230913","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/hep.29219","article-title":"Development of a novel frailty index to predict mortality in patients with end-stage liver disease","volume":"66","author":"Lai","year":"2017","journal-title":"Hepatology"},{"key":"R44-20230913","article-title":"Multicenter study of age, frailty, and waitlist mortality among liver transplant candidates","author":"Haugen","year":"2019","journal-title":"Ann Surg"},{"key":"R45-20230913","doi-asserted-by":"crossref","first-page":"899","DOI":"10.3748\/wjg.v23.i5.899","article-title":"Frailty is independently associated with increased hospitalisation days in patients on the liver transplant waitlist","volume":"23","author":"Sinclair","year":"2017","journal-title":"World J Gastroenterol"},{"key":"R46-20230913","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1097\/TP.0000000000002741","article-title":"Sarcopenia predicts posttransplant mortality in acutely ill men undergoing urgent evaluation and liver transplantation","volume":"103","author":"Kuo","year":"2019","journal-title":"Transplantation"},{"key":"R47-20230913","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.clnu.2018.12.022","article-title":"ESPEN guideline on clinical nutrition in liver disease","volume":"38","author":"Plauth","year":"2019","journal-title":"Clin Nutr"}],"container-title":["Current Opinion in Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MCC.0000000000000700","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T19:36:38Z","timestamp":1694633798000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MCC.0000000000000700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/mcc.0000000000000700","relation":{},"ISSN":["1070-5295","1531-7072"],"issn-type":[{"type":"print","value":"1070-5295"},{"type":"electronic","value":"1531-7072"}],"subject":[],"published":{"date-parts":[[2020,4]]}}}